♥
ISIN : INE306L01010
NSE : QUICKHEAL
BSE : 539678
Face Value : 10
Industry : IT - Software
EPS : 4.48
EPS (TTM) : 5.92
Price to Earning (P/E) : 64.10
Book Value : 79.81
Price to Bookvalue (P/B) : 3.60
Dividend Yield : 1 %
Return on Equity (ROE) : 5.79 %
Return on Capital Employed (ROCE) : 6.15 %
Quick Heal Technologies Limited
ISIN : INE306L01010
NSE : QUICKHEAL
BSE : 539678
Face Value : 10
Industry : IT - Software
EPS : 4.48
EPS (TTM) : 5.92
Price to Earning (P/E) : 64.10
Book Value : 79.81
Price to Bookvalue (P/B) : 3.60
Dividend Yield : 1 %
Return on Equity (ROE) : 5.79 %
Return on Capital Employed (ROCE) : 6.15 %
Quick Heal share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 136.55 - 141.7 3.8 % |
| Low / High | 135.15 - 142.6 5.5 % |
| Trade Volume | 10,968 |
| 52 Week Low / High | 125 - 416 232.8 % |
-
YOU MAY ALSO LIKE
- Share Market basics for beginners
Share Market jargons in simple terms - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - Stock market course tutorial
Stock Market Investment Course explained in simple words. - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
CONSOLIDATED QUARTERLY RESULT FOR QUICK HEAL TECHNOLOGIES LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 610.8 | 1009.4 | 668 | 492.8 | 514.4 | 783.6 | 819.2 | 800.3 | 702.9 | 734.9 |
| Total Income | 642.8 | 1063.4 | 702.7 | 593.4 | 561.7 | 840.5 | 860.7 | 868.5 | 753.5 | 786.9 |
| Total Expenditure | 600.3 | 725.6 | 781.7 | 654.5 | 665.2 | 673.9 | 703 | 699.9 | 677 | 704.2 |
| Other Income | 32 | 54 | 34.7 | 100.6 | 47.3 | 56.9 | 41.5 | 68.2 | 50.6 | 52 |
| Operating Profit | 42.5 | 337.8 | -79 | -61.1 | -103.5 | 166.6 | 157.7 | 168.6 | 76.5 | 82.7 |
| Interest | 1.3 | 0.5 | 0.5 | |||||||
| PBDT | 42.5 | 337.8 | -79 | -61.1 | -103.5 | 166.6 | 157.7 | 167.3 | 76 | 82.2 |
| Depreciation | 39.5 | 41.4 | 41.7 | 37.3 | 29.3 | 32.5 | 32.4 | 31.8 | 27.9 | 31.5 |
| Profit Before Tax | 3 | 296.4 | -120.7 | -98.4 | -132.8 | 134.1 | 125.3 | 135.5 | 48.1 | 50.7 |
| Tax | 1.2 | 74.8 | -27.8 | -32 | -5.2 | 5.1 | 24.7 | -4.9 | 7.8 | 9.2 |
| Profit After Tax | 1.8 | 221.6 | -92.9 | -66.4 | -127.6 | 129 | 100.6 | 140.4 | 40.3 | 41.5 |
| Net Profit | 1.8 | 221.6 | -92.9 | -66.4 | -127.6 | 129 | 100.6 | 140.4 | 40.3 | 41.5 |
| Equity Capital | 580.2 | 580.7 | 530.7 | 530.7 | 530.7 | 530.8 | 533.2 | 535.1 | 535.4 | 538 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 0.03 | 3.82 | -1.75 | -1.25 | -2.4 | 2.43 | 1.89 | 2.62 | 0.75 | 0.77 |
| Diluted Eps After Extraordinary Items | 0.03 | 3.81 | -1.7 | -1.25 | -2.4 | 2.42 | 1.86 | 2.57 | 0.74 | 0.75 |
| Diluted Eps Before Extraordinary Items | 0.03 | 3.81 | -1.7 | -1.25 | -2.4 | 2.42 | 1.86 | 2.57 | 0.74 | 0.75 |
STANDALONE QUARTERLY RESULT FOR QUICK HEAL TECHNOLOGIES LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 610.9 | 1009.3 | 668 | 492.9 | 514.3 | 783.7 | 819.2 | 800.3 | 702.9 | 735.7 |
| Total Income | 642.8 | 1063.1 | 706.5 | 592.5 | 561.6 | 840.5 | 860.6 | 868.5 | 753.5 | 787.8 |
| Total Expenditure | 599.3 | 725.9 | 775.2 | 652.7 | 666.3 | 673.9 | 703.3 | 700 | 676.7 | 706.9 |
| Other Income | 31.9 | 53.8 | 38.5 | 99.6 | 47.3 | 56.8 | 41.4 | 68.2 | 50.6 | 52.1 |
| Operating Profit | 43.5 | 337.2 | -68.7 | -60.2 | -104.7 | 166.6 | 157.3 | 168.5 | 76.8 | 80.9 |
| Interest | 1.3 | 0.5 | 0.5 | |||||||
| Exceptional Items | 1 | |||||||||
| PBDT | 43.5 | 337.2 | -67.7 | -60.2 | -104.7 | 166.6 | 157.3 | 167.2 | 76.3 | 80.4 |
| Depreciation | 39.5 | 41.4 | 41.7 | 37.3 | 29.3 | 32.5 | 32.4 | 31.8 | 27.9 | 31.5 |
| Profit Before Tax | 4 | 295.8 | -109.4 | -97.5 | -134 | 134.1 | 124.9 | 135.4 | 48.4 | 48.9 |
| Tax | 1 | 74.7 | -27.8 | -32 | -5.2 | 5.1 | 24.7 | -4.9 | 7.8 | 9.2 |
| Profit After Tax | 3 | 221.1 | -81.6 | -65.5 | -128.8 | 129 | 100.2 | 140.3 | 40.6 | 39.7 |
| Net Profit | 3 | 221.1 | -81.6 | -65.5 | -128.8 | 129 | 100.2 | 140.3 | 40.6 | 39.7 |
| Equity Capital | 580.2 | 580.7 | 530.7 | 530.7 | 530.7 | 530.8 | 533.2 | 535.1 | 535.4 | 538 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 0.05 | 3.81 | -1.54 | -1.23 | -2.43 | 2.43 | 1.88 | 2.62 | 0.76 | 0.74 |
| Diluted Eps After Extraordinary Items | 0.05 | 3.8 | -1.5 | -1.23 | -2.43 | 2.42 | 1.85 | 2.57 | 0.74 | 0.72 |
| Diluted Eps Before Extraordinary Items | 0.05 | 3.8 | -1.5 | -1.23 | -2.43 | 2.42 | 1.85 | 2.57 | 0.74 | 0.72 |
CONSOLIDATED ANNUAL RESULT FOR QUICK HEAL TECHNOLOGIES LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 3419 | 2780.9 | 2917.5 |
| Total Income | 3611 | 3002.2 | 3131.4 |
| Total Expenditure | 2350.4 | 2762.1 | 2742 |
| Other Income | 192 | 221.3 | 213.9 |
| Operating Profit | 1260.6 | 240.1 | 389.4 |
| Interest | 1.3 | ||
| PBDT | 1260.6 | 240.1 | 388.1 |
| Depreciation | 173.8 | 159.9 | 126 |
| Profit Before Tax | 1086.8 | 80.2 | 262.1 |
| Tax | 254.9 | 16.2 | 19.7 |
| Profit After Tax | 831.9 | 64 | 242.4 |
| Net Profit | 831.9 | 64 | 242.4 |
| Equity Capital | 580.1 | 530.7 | 535.1 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 5696.2 | 3666.4 | 3834.9 |
| Calculated EPS | 14.34 | 1.21 | 4.53 |
| Diluted Eps After Extraordinary Items | 13.94 | 1.14 | 4.48 |
| Diluted Eps Before Extraordinary Items | 13.94 | 1.14 | 4.48 |
STANDALONE ANNUAL RESULT FOR QUICK HEAL TECHNOLOGIES LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 3415.5 | 2781.1 | 2917.5 |
| Total Income | 3607.2 | 3004.9 | 3131.2 |
| Total Expenditure | 2357.2 | 2753.1 | 2743.5 |
| Other Income | 191.7 | 223.8 | 213.7 |
| Operating Profit | 1250 | 251.8 | 387.7 |
| Interest | 1.3 | ||
| Exceptional Items | -40.6 | 1 | |
| PBDT | 1209.4 | 252.8 | 386.4 |
| Depreciation | 173.8 | 159.9 | 126 |
| Profit Before Tax | 1035.6 | 92.9 | 260.4 |
| Tax | 253.7 | 15.9 | 19.7 |
| Profit After Tax | 781.9 | 77 | 240.7 |
| Net Profit | 781.9 | 77 | 240.7 |
| Equity Capital | 580.1 | 530.7 | 535.1 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 5692 | 3666.5 | 3833.9 |
| Calculated EPS | 13.48 | 1.45 | 4.5 |
| Diluted Eps After Extraordinary Items | 13.1 | 1.37 | 4.45 |
| Diluted Eps Before Extraordinary Items | 13.1 | 1.37 | 4.45 |
CONSOLIDATED PROFIT / LOSS FOR QUICK HEAL TECHNOLOGIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Operating Income | 333.04 Cr | 341.9 Cr | 278.09 Cr | 291.75 Cr |
| Software Services & Operating Revenues | 333.04 Cr | 341.9 Cr | 278.09 Cr | 291.75 Cr |
| Operating Income (Net) | 333.04 Cr | 341.9 Cr | 278.09 Cr | 291.75 Cr |
| Stock Adjustments | 2.28 Cr | -1.85 Cr | 39 Lk | 1.29 Cr |
| Raw Material Consumed | 9.36 Cr | 14.01 Cr | 8.94 Cr | 5.54 Cr |
| Opening Raw Materials | 1.34 Cr | 71 Lk | 31 Lk | 41 Lk |
| Purchases Raw Materials | 40 Lk | 61 Lk | 1.21 Cr | 0 |
| Closing Raw Materials | 70.8 Lk | 31 Lk | 41 Lk | 0 |
| Other Direct Purchases / Brought in cost | 8.33 Cr | 13 Cr | 7.83 Cr | 5.13 Cr |
| Power & Fuel Cost | 2.37 Cr | 2.38 Cr | 2.59 Cr | 2.7 Cr |
| Electricity & Power | 2.37 Cr | 2.38 Cr | 2.59 Cr | 2.7 Cr |
| Employee Cost | 114.74 Cr | 139.49 Cr | 154.9 Cr | 169.03 Cr |
| Salaries, Wages & Bonus | 107.6 Cr | 126.69 Cr | 142.35 Cr | 153.92 Cr |
| Contributions to EPF & Pension Funds | 2.66 Cr | 3.19 Cr | 3.98 Cr | 4.3 Cr |
| Wheeling & Transmission Charges recoverable | 2.03 Cr | 2.77 Cr | 3.28 Cr | 3.54 Cr |
| Cost of Software developments | 7.47 Cr | 8.21 Cr | 9.28 Cr | 10.75 Cr |
| Operating Expenses | 3.18 Cr | 2.92 Cr | 2.89 Cr | 2.95 Cr |
| Repairs and Maintenance | 3.18 Cr | 2.92 Cr | 2.89 Cr | 2.95 Cr |
| General and Administration Expenses | 24.68 Cr | 34.21 Cr | 52.67 Cr | 51.94 Cr |
| Rates & Taxes | 1.19 Cr | 88 Lk | 1.17 Cr | 81 Lk |
| Insurance | 37.3 Lk | 41 Lk | 43 Lk | 49 Lk |
| Professional and legal fees | 9.33 Cr | 14.78 Cr | 26.3 Cr | 19.61 Cr |
| Selling and Marketing Expenses | 23.31 Cr | 28.24 Cr | 34.78 Cr | 19.3 Cr |
| Advertisement & Sales Promotion | 22.62 Cr | 27.68 Cr | 34.3 Cr | 18.75 Cr |
| Freight outwards | 69.5 Lk | 56 Lk | 48 Lk | 55 Lk |
| Miscellaneous Expenses | 8 Cr | 7.43 Cr | 9.77 Cr | 10.7 Cr |
| Bad debts /advances written off | 3.48 Cr | 8 Lk | 0 | 0 |
| Provision for doubtful debts | 0 | 3.36 Cr | 0 | 0 |
| Loss on foreign exchange fluctuations | 15.3 Lk | 0 | 71 Lk | 15 Lk |
| Total Expenditure | 195.39 Cr | 235.04 Cr | 276.21 Cr | 274.2 Cr |
| Other Income | 27.97 Cr | 19.2 Cr | 22.13 Cr | 21.39 Cr |
| Interest Received | 7.13 Cr | 2.9 Cr | 1.78 Cr | 1.29 Cr |
| Profit on sale of Fixed Assets | 3.7 Lk | 2.5 Cr | 3.95 Cr | 27 Lk |
| Profits on sale of Investments | 3.01 Cr | 2.84 Cr | 3.2 Cr | 2.02 Cr |
| Provision Written Back | 3.81 Cr | 0 | 0 | 0 |
| Operating Profit | 165.62 Cr | 126.06 Cr | 24.01 Cr | 38.94 Cr |
| Interest | 0 | 0 | 0 | 13 Lk |
| PBDT | 165.62 Cr | 126.06 Cr | 24.01 Cr | 38.81 Cr |
| Depreciation | 19.49 Cr | 17.38 Cr | 15.99 Cr | 12.6 Cr |
| Profit Before Taxation & Exceptional Items | 146.14 Cr | 108.68 Cr | 8.02 Cr | 26.21 Cr |
| Profit Before Tax | 146.14 Cr | 108.68 Cr | 8.02 Cr | 26.21 Cr |
| Provision for Tax | 39.16 Cr | 25.49 Cr | 1.62 Cr | 1.97 Cr |
| Current Income Tax | 34.04 Cr | 25.88 Cr | 1.28 Cr | 5.78 Cr |
| Deferred Tax | 3.36 Cr | -1.04 Cr | 48 Lk | -3.88 Cr |
| Profit After Tax | 106.98 Cr | 83.19 Cr | 6.4 Cr | 24.24 Cr |
| Consolidated Net Profit | 106.98 Cr | 83.19 Cr | 6.4 Cr | 24.24 Cr |
| Profit Balance B/F | 470.78 Cr | 576.2 Cr | 502.9 Cr | 302.14 Cr |
| Appropriations | 577.76 Cr | 659.39 Cr | 509.3 Cr | 326.38 Cr |
| Equity Dividend % | 40 | 45 | 25 | 30 |
| Earnings Per Share | 16.66 | 14.34 | 1.21 | 4.53 |
| Adjusted EPS | 16.66 | 14.34 | 1.21 | 4.53 |
STANDALONE PROFIT / LOSS FOR QUICK HEAL TECHNOLOGIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Operating Income | 333.53 Cr | 341.55 Cr | 278.11 Cr | 291.75 Cr |
| Software Services & Operating Revenues | 333.53 Cr | 341.55 Cr | 278.11 Cr | 291.75 Cr |
| Operating Income (Net) | 333.53 Cr | 341.55 Cr | 278.11 Cr | 291.75 Cr |
| Stock Adjustments | 2.3 Cr | -1.89 Cr | 39 Lk | 1.29 Cr |
| Raw Material Consumed | 9.07 Cr | 14.3 Cr | 8.94 Cr | 5.54 Cr |
| Opening Raw Materials | 1.34 Cr | 70 Lk | 31 Lk | 41 Lk |
| Purchases Raw Materials | 40 Lk | 61 Lk | 1.21 Cr | 0 |
| Closing Raw Materials | 70.8 Lk | 31 Lk | 41 Lk | 0 |
| Other Direct Purchases / Brought in cost | 8.04 Cr | 13.3 Cr | 7.83 Cr | 5.13 Cr |
| Power & Fuel Cost | 2.35 Cr | 2.36 Cr | 2.59 Cr | 2.7 Cr |
| Electricity & Power | 2.35 Cr | 2.36 Cr | 2.59 Cr | 2.7 Cr |
| Employee Cost | 113.2 Cr | 138.34 Cr | 154.89 Cr | 168.94 Cr |
| Salaries, Wages & Bonus | 106.21 Cr | 125.6 Cr | 142.34 Cr | 153.83 Cr |
| Contributions to EPF & Pension Funds | 2.5 Cr | 3.13 Cr | 3.98 Cr | 4.3 Cr |
| Wheeling & Transmission Charges recoverable | 2.03 Cr | 2.77 Cr | 3.28 Cr | 3.54 Cr |
| Cost of Software developments | 7.47 Cr | 8.21 Cr | 9.28 Cr | 10.75 Cr |
| Operating Expenses | 3.09 Cr | 2.92 Cr | 2.89 Cr | 2.95 Cr |
| Repairs and Maintenance | 3.09 Cr | 2.92 Cr | 2.89 Cr | 2.95 Cr |
| General and Administration Expenses | 23.45 Cr | 33.73 Cr | 52.39 Cr | 51.81 Cr |
| Rates & Taxes | 1.15 Cr | 87 Lk | 1.12 Cr | 80 Lk |
| Insurance | 37.3 Lk | 38 Lk | 43 Lk | 49 Lk |
| Professional and legal fees | 8.46 Cr | 14.51 Cr | 26.15 Cr | 19.53 Cr |
| Selling and Marketing Expenses | 27.22 Cr | 30.27 Cr | 35.36 Cr | 20.12 Cr |
| Advertisement & Sales Promotion | 26.53 Cr | 29.71 Cr | 34.88 Cr | 19.57 Cr |
| Freight outwards | 68.8 Lk | 56 Lk | 48 Lk | 55 Lk |
| Miscellaneous Expenses | 7.87 Cr | 7.48 Cr | 8.58 Cr | 10.25 Cr |
| Bad debts /advances written off | 3.47 Cr | 6 Lk | 0 | 0 |
| Loss on foreign exchange fluctuations | 28.9 Lk | 9 Lk | 0 | 15 Lk |
| Total Expenditure | 196.01 Cr | 235.72 Cr | 275.31 Cr | 274.35 Cr |
| Other Income | 27.8 Cr | 19.17 Cr | 22.38 Cr | 21.37 Cr |
| Interest Received | 7.13 Cr | 2.9 Cr | 1.78 Cr | 1.29 Cr |
| Profit on sale of Fixed Assets | 3.7 Lk | 2.51 Cr | 3.95 Cr | 27 Lk |
| Profits on sale of Investments | 3.01 Cr | 2.84 Cr | 3.2 Cr | 2.02 Cr |
| Provision Written Back | 3.86 Cr | 0 | 0 | 0 |
| Foreign Exchange Gains | 0 | 0 | 29 Lk | 0 |
| Operating Profit | 165.32 Cr | 125 Cr | 25.18 Cr | 38.77 Cr |
| Interest | 0 | 0 | 0 | 13 Lk |
| PBDT | 165.32 Cr | 125 Cr | 25.18 Cr | 38.64 Cr |
| Depreciation | 19.48 Cr | 17.38 Cr | 15.99 Cr | 12.6 Cr |
| Profit Before Taxation & Exceptional Items | 145.84 Cr | 107.62 Cr | 9.19 Cr | 26.04 Cr |
| Exceptional Income / Expenses | 0 | -4.06 Cr | 10 Lk | 0 |
| Profit Before Tax | 145.84 Cr | 103.56 Cr | 9.29 Cr | 26.04 Cr |
| Provision for Tax | 39.04 Cr | 25.37 Cr | 1.59 Cr | 1.97 Cr |
| Current Income Tax | 33.92 Cr | 25.76 Cr | 1.25 Cr | 5.78 Cr |
| Deferred Tax | 3.36 Cr | -1.04 Cr | 48 Lk | -3.88 Cr |
| Profit After Tax | 106.79 Cr | 78.19 Cr | 7.7 Cr | 24.07 Cr |
| Consolidated Net Profit | 106.79 Cr | 78.19 Cr | 7.7 Cr | 24.07 Cr |
| Profit Balance B/F | 474.76 Cr | 579.99 Cr | 501.7 Cr | 302.24 Cr |
| Appropriations | 581.55 Cr | 658.18 Cr | 509.4 Cr | 326.31 Cr |
| Equity Dividend % | 40 | 45 | 25 | 30 |
| Earnings Per Share | 16.63 | 13.48 | 1.45 | 4.5 |
| Adjusted EPS | 16.63 | 13.48 | 1.45 | 4.5 |
CONSOLIDATED CASH FLOW FOR QUICK HEAL TECHNOLOGIES LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 146.14 Cr | 108.68 Cr | 8.02 Cr | 26.21 Cr |
| Adjustment | 31.1 Lk | 10.65 Cr | 3.57 Cr | 6.03 Cr |
| Changes In working Capital | -18.29 Cr | -5.2 Cr | 27.22 Cr | -14.08 Cr |
| Cash Flow after changes in Working Capital | 128.15 Cr | 114.13 Cr | 38.81 Cr | 18.16 Cr |
| Cash Flow from Operating Activities | 98.85 Cr | 80.83 Cr | 30.81 Cr | 18.19 Cr |
| Cash Flow from Investing Activities | -92.53 Cr | 124.81 Cr | 185.23 Cr | 6.15 Cr |
| Cash Flow from Financing Activitie | 9.9 Lk | -214.16 Cr | -212.16 Cr | 1.6 Cr |
| Net Cash Inflow / Outflow | 6.42 Cr | -8.52 Cr | 3.88 Cr | 25.94 Cr |
| Opening Cash & Cash Equivalents | 10.07 Cr | 16.43 Cr | 7.83 Cr | 11.58 Cr |
| Effect of Foreign Exchange Fluctuations | -7 Lk | -8 Lk | -13 Lk | -1 Lk |
| Closing Cash & Cash Equivalent | 16.42 Cr | 7.83 Cr | 11.58 Cr | 37.51 Cr |
STANDALONE CASH FLOW FOR QUICK HEAL TECHNOLOGIES LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 145.84 Cr | 103.56 Cr | 9.29 Cr | 26.04 Cr |
| Adjustment | 24 Lk | 14.91 Cr | 2.46 Cr | 6.39 Cr |
| Changes In working Capital | -16.35 Cr | -7.07 Cr | 27.17 Cr | -14.04 Cr |
| Cash Flow after changes in Working Capital | 129.73 Cr | 111.4 Cr | 38.92 Cr | 18.39 Cr |
| Cash Flow from Operating Activities | 100.57 Cr | 79.06 Cr | 30.99 Cr | 18.42 Cr |
| Cash Flow from Investing Activities | -94.69 Cr | 129.55 Cr | 187.5 Cr | 6.15 Cr |
| Cash Flow from Financing Activitie | 9.9 Lk | -214.14 Cr | -212.17 Cr | 1.6 Cr |
| Net Cash Inflow / Outflow | 5.98 Cr | -5.53 Cr | 6.32 Cr | 26.17 Cr |
| Opening Cash & Cash Equivalents | 3.56 Cr | 9.5 Cr | 3.97 Cr | 10.29 Cr |
| Closing Cash & Cash Equivalent | 9.54 Cr | 3.97 Cr | 10.29 Cr | 36.46 Cr |
CONSOLIDATED BALANCE SHEET FOR QUICK HEAL TECHNOLOGIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
STANDALONE BALANCE SHEET FOR QUICK HEAL TECHNOLOGIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
FINANCIAL RATIOS (CONSOLIDATED) FOR QUICK HEAL TECHNOLOGIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 16.66 | 14.34 | 1.21 | 4.53 |
| CEPS(Rs) | 19.7 | 17.34 | 4.22 | 6.88 |
| DPS(Rs) | 4 | 4.5 | 2.5 | 3 |
| Book NAV/Share(Rs) | 116.57 | 106.98 | 77.29 | 79.81 |
| Tax Rate(%) | 26.79 | 23.45 | 20.2 | 7.52 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 41.33 | 31.25 | 0.68 | 6.02 |
| EBIT Margin(%) | 43.88 | 31.79 | 2.88 | 9.03 |
| Pre Tax Margin(%) | 43.88 | 31.79 | 2.88 | 8.98 |
| PAT Margin (%) | 32.12 | 24.33 | 2.3 | 8.31 |
| Cash Profit Margin (%) | 37.97 | 29.42 | 8.05 | 12.63 |
| Performance Ratios | ||||
| ROA(%) | 14.07 | 10.79 | 1.06 | 4.84 |
| ROE(%) | 15.39 | 12.15 | 1.24 | 5.79 |
| ROCE(%) | 20.94 | 15.76 | 1.53 | 6.15 |
| Asset Turnover(x) | 0.44 | 0.44 | 0.46 | 0.58 |
| Sales/Fixed Asset(x) | 1.06 | 1.09 | 0.99 | 1.08 |
| Working Capital/Sales(x) | 0.6 | 0.76 | 1.11 | 1 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.94 | 0.92 | 1.01 | 0.93 |
| Receivable days | 144.55 | 172.19 | 193.34 | 159.12 |
| Inventory Days | 5.25 | 4.34 | 6.1 | 4.57 |
| Payable days | 93.45 | 1729.4 | 1923 | 2364.48 |
| Valuation Parameters | ||||
| PER(x) | 11.2 | 12.38 | 110.45 | 103.91 |
| PCE(x) | 9.47 | 10.24 | 31.57 | 68.37 |
| Price/Book(x) | 1.6 | 1.66 | 1.72 | 5.9 |
| Yield(%) | 2.14 | 2.53 | 1.88 | 0.64 |
| EV/Net Sales(x) | 3.34 | 2.83 | 2.5 | 8.5 |
| EV/Core EBITDA(x) | 6.72 | 7.67 | 28.95 | 63.71 |
| EV/EBIT(x) | 7.62 | 8.9 | 86.66 | 94.19 |
| EV/CE(x) | 1.35 | 1.35 | 1.41 | 5.68 |
| M Cap / Sales | 3.6 | 3.01 | 2.54 | 8.63 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 16.39 | 2.66 | -18.66 | 4.91 |
| Core EBITDA Growth(%) | 34.67 | -23.89 | -80.95 | 62.18 |
| EBIT Growth(%) | 44.25 | -25.63 | -92.62 | 228.43 |
| PAT Growth(%) | 43.77 | -22.23 | -92.31 | 278.75 |
| EPS Growth(%) | 43.76 | -13.92 | -91.59 | 275.62 |
| Financial Stability Ratios | ||||
| Current Ratio(x) | 8.53 | 6.2 | 4.5 | 4.96 |
| Quick Ratio(x) | 8.49 | 6.15 | 4.43 | 4.93 |
| Interest Cover(x) | 0 | 0 | 0 | 202.62 |
FINANCIAL RATIOS (STANDALONE) FOR QUICK HEAL TECHNOLOGIES LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 16.63 | 13.48 | 1.45 | 4.5 |
| CEPS(Rs) | 19.67 | 16.47 | 4.46 | 6.85 |
| DPS(Rs) | 4 | 4.5 | 2.5 | 3 |
| Book NAV/Share(Rs) | 117.24 | 106.91 | 77.3 | 79.79 |
| Tax Rate(%) | 26.77 | 24.5 | 17.12 | 7.57 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 41.23 | 30.99 | 1.01 | 5.96 |
| EBIT Margin(%) | 43.73 | 30.32 | 3.34 | 8.97 |
| Pre Tax Margin(%) | 43.73 | 30.32 | 3.34 | 8.93 |
| PAT Margin (%) | 32.02 | 22.89 | 2.77 | 8.25 |
| Cash Profit Margin (%) | 37.86 | 27.98 | 8.52 | 12.57 |
| Performance Ratios | ||||
| ROA(%) | 13.98 | 10.11 | 1.27 | 4.8 |
| ROE(%) | 15.27 | 11.39 | 1.49 | 5.75 |
| ROCE(%) | 20.77 | 14.98 | 1.77 | 6.11 |
| Asset Turnover(x) | 0.44 | 0.44 | 0.46 | 0.58 |
| Sales/Fixed Asset(x) | 1.06 | 1.09 | 0.99 | 1.08 |
| Working Capital/Sales(x) | 0.61 | 0.77 | 1.11 | 1.01 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.94 | 0.92 | 1.01 | 0.93 |
| Receivable days | 143.74 | 172.25 | 194.04 | 159.4 |
| Inventory Days | 5.21 | 4.32 | 6.1 | 4.57 |
| Payable days | 91.75 | 1697.35 | 1933.76 | 2372.23 |
| Valuation Parameters | ||||
| PER(x) | 11.22 | 13.17 | 91.8 | 104.64 |
| PCE(x) | 9.49 | 10.78 | 29.84 | 68.69 |
| Price/Book(x) | 1.59 | 1.66 | 1.72 | 5.9 |
| Yield(%) | 2.14 | 2.53 | 1.88 | 0.64 |
| EV/Net Sales(x) | 3.36 | 2.84 | 2.5 | 8.51 |
| EV/Core EBITDA(x) | 6.78 | 7.77 | 27.65 | 64.02 |
| EV/EBIT(x) | 7.68 | 9.37 | 74.96 | 94.84 |
| EV/CE(x) | 1.35 | 1.36 | 1.41 | 5.68 |
| M Cap / Sales | 3.59 | 3.02 | 2.54 | 8.63 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 17.69 | 2.4 | -18.57 | 4.9 |
| Core EBITDA Growth(%) | 32.87 | -24.38 | -79.86 | 53.97 |
| EBIT Growth(%) | 45.2 | -28.98 | -91.03 | 181.7 |
| PAT Growth(%) | 45.02 | -26.77 | -90.15 | 212.6 |
| EPS Growth(%) | 45.01 | -18.95 | -89.24 | 210.03 |
| Financial Stability Ratios | ||||
| Current Ratio(x) | 8.46 | 6.14 | 4.51 | 4.95 |
| Quick Ratio(x) | 8.42 | 6.08 | 4.44 | 4.91 |
| Interest Cover(x) | 0 | 0 | 0 | 201.31 |
SHARE HOLDING PATTERN FOR QUICK HEAL TECHNOLOGIES LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 72.84 | 72.78 | 73.08 | 73.08 | 73.08 | 73.06 | 72.76 | 72.48 | 72.44 | 72.08 |
| FII % | 1.74 | 1.76 | 2.17 | 2.04 | 2.02 | 1.56 | 1.66 | 1.65 | 1.54 | 1.61 |
| DII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.13 | 1.44 | 1.59 | 1.58 | 1.56 |
| Public % | 25.42 | 25.46 | 24.75 | 24.88 | 24.90 | 24.25 | 24.14 | 23.81 | 23.61 | 23.68 |
PEER COMPARISON FOR QUICK HEAL TECHNOLOGIES LIMITED
CORPORATE ACTIONS FOR QUICK HEAL
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 11-Oct-2024 | Board Meeting - Quarterly Results | 17-Oct-2024 |
| BSE 19-Aug-2024 | Book Closure - A.G.M. | 31-Aug-2024 06-Sep-2024 |
| BSE 19-Aug-2024 | AGM - A.G.M. | 06-Sep-2024 06-Sep-2024 |
| BSE 18-Jul-2024 | Board Meeting - Quarterly Results | 26-Jul-2024 |
| BSE 26-Apr-2024 | Dividend - Rs.3.0000 per share(30%)Final Dividend | |
| BSE 18-Apr-2024 | Board Meeting - Final Dividend & Audited Results | 25-Apr-2024 |
| BSE 10-Jan-2024 | Board Meeting - Quarterly Results | 24-Jan-2024 |
| BSE 16-Oct-2023 | Board Meeting - Quarterly Results | 26-Oct-2023 |
| BSE 14-Jul-2023 | Board Meeting - Quarterly Results | 20-Jul-2023 |
| BSE 17-Apr-2023 | Dividend - Rs.2.5000 per share(25%)Final Dividend | |
| BSE 11-Apr-2023 | Board Meeting - Final Dividend & Audited Results | 17-Apr-2023 |
| BSE 16-Jan-2023 | Board Meeting - Quarterly Results | 24-Jan-2023 |
| BSE 17-Oct-2022 | Board Meeting - Quarterly Results | 19-Oct-2022 |
| BSE 01-Aug-2022 | Book Closure - Rs.4.5000 per share(45%)Final Dividend & A.G.M. | 20-Aug-2022 26-Aug-2022 |
| BSE 01-Aug-2022 | AGM - Rs.4.5000 per share(45%)Final Dividend & A.G.M. | 26-Aug-2022 26-Aug-2022 |
| BSE 15-Jul-2022 | Board Meeting - Buy Back of Shares & Quarterly Results | 21-Jul-2022 |
| BSE 05-May-2022 | Dividend - Rs.4.5000 per share(45%)Final Dividend | |
| BSE 29-Apr-2022 | Board Meeting - Audited Results & Final Dividend | 05-May-2022 |
| BSE 18-Jan-2022 | Board Meeting - Quarterly Results | 24-Jan-2022 |
| BSE 18-Oct-2021 | Board Meeting - Quarterly Results | 25-Oct-2021 |
CORPORATE ANNOUNCEMENTS FOR QUICK HEAL
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 25-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of Earning Call held on 18 October 2024 |
| BSE 25-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Allotment of 50150 equity shares under ESOP 2014 scheme and ESOP 2021 scheme |
| BSE 19-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication NEWSPAPER PUBLICATION OF FINANCIAL RESULTS FOR QUARTER ENDED 30 SEPTEMBER 2024 |
| BSE 19-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Outcome of Earnings Call for Q2 FY 2025 |
| BSE 17-Oct-2024 | Outcome FILE | Half Yearly Results For FY 2024-25 Half Yearly Results for FY 2024-25 |
| BSE 17-Oct-2024 | Outcome FILE | Board Meeting Outcome for Half Yearly Results FY 2024-25 Half Yearly Results FY 2024-25 |
| BSE 14-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Earnings Call for Quarter 2 Financial year 2024-25 |
| BSE 11-Oct-2024 | Intimation FILE | Board Meeting Intimation for The Quarter And Half Year Results For The Year Ended 30 September 2024 Quick Heal Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2024 inter alia to consider and approve the quarter and half year results for the year ended 30 September 2024 |
| BSE 07-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under 74 (5) |
| BSE 04-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS ALLOTMENT OF 44935 EQUITY SHARES UNDER ESOP 2014 AND ESOP 2021 SCHEME |
| BSE 03-Oct-2024 | General Announcements FILE | New Product Launch New Product Launch - AntiFraud.AI |
| BSE 25-Sep-2024 | Intimation FILE | Closure of Trading Window Closure of Trading Window |
| BSE 09-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s Re-Appointment of MSKA & Associates as Statutory Auditors at the Annual General Meeting. |
| BSE 09-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Directorate Appointment of Mr. Kamal Kumar Agarwal at the Annual General Meeting. |
| BSE 09-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Directorate Appointment of Mr. Amitabha Mukhopadhyay at the Annual General Meeting. |
| BSE 09-Sep-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Scrutinizers Report on remove E-voting prior and during AGM and voting results as prescribed in format pursuant to regulation 44 (3) of LODR. |
| BSE 06-Sep-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Outcome of Annual General Meeting held on 6th September 2024 at 4 p.m. |
| BSE 02-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Allotment of under 28725 under ESOP Scheme 2014 and ESOP Scheme 2021 |
| BSE 17-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication of 29th Annual General Meeting |
| BSE 15-Aug-2024 | Intimation FILE | The Register Of Members And Share Transfer Books Of The Company Will Be Closed From August 31 2024 To September 6 2024 Both Days Inclusive The Register of Members and share transfer books of the Company will be closed from August 31 2024 to September 6 2024 both days inclusive |
| BSE 15-Aug-2024 | Intimation FILE | The Register Of Members And Share Transfer Books Of The Company Will Be Closed From August 31 2024 To September 6 2024 Both Days Inclusive The Register of members and share transfer books of the Company will be closed from August 31 2024 to September 6 2024 both day inclusive |
| BSE 15-Aug-2024 | General Announcements FILE | Notice Of Annual General Meeting To Be Held On September 6 2024 Notice of Annual General Meeting to be held on September 6 2024 |
| BSE 15-Aug-2024 | General Announcements FILE | Business Responsibility and Sustainability Reporting (BRSR) Business Responsibility and Sustainability Report for the Financial Year 2023-24 |
| BSE 15-Aug-2024 | General Announcements FILE | Reg. 34 (1) Annual Report. Annual Report for the Financial Year 2023-24 |
| BSE 15-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Public Notice of 28th Annual General Meeting to be held on September 6 2024 at 4:00 PM. |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Allotment of 199535 Equity Shares under ESOP Scheme 2014 and ESOP Scheme 2021 |
| BSE 07-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investor Meet |
| BSE 05-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of earning call held on July 29 2024 |
| BSE 30-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Outcome of Earning Call for Q1 FY25 |
| BSE 29-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication NEWSPAPER PUBLICATION OF FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30 2024 |
INSIDER TRADING FOR QUICK HEAL
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 21-Oct-2024 21-Oct-2024 | Sell Market | 3,386 @ 0.00 (0.00 %) | Deepak Mishra |
| BSE 26-Sep-2024 26-Sep-2024 | Sell Market | 1,025 @ 0.00 (0.00 %) | SOURAV BISWAS |
| BSE 25-Sep-2024 25-Sep-2024 | Sell Invocation Of Pledged | 2,500 @ 0.00 (0.00 %) | Omkar Yekkundi |
| BSE 26-Aug-2024 26-Aug-2024 | Sell Market | 14,300 @ 0.00 (0.00 %) | RANVIJAI BHADAURIA |
| BSE 05-Jul-2024 05-Jul-2024 | Buy ESOP | 375 @ 0.00 (0.00 %) | Sopan Jagtap |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 375 @ 0.00 (0.00 %) | Sopan Jagtap |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 500 @ 0.00 (0.00 %) | Sopan Jagtap |
| BSE 22-Aug-2024 22-Aug-2024 | Sell Market | 1,500 @ 0.00 (0.00 %) | Sopan Jagtap |
| BSE 22-Aug-2024 22-Aug-2024 | Sell Market | 2,000 @ 0.00 (0.01 %) | RANVIJAI SINGH BHADHURIA |
| BSE 26-Aug-2024 26-Aug-2024 | Sell Market | 7,614 @ 0.00 (0.00 %) | Deepak Mishra |
| BSE 22-Aug-2024 22-Aug-2024 | Sell Market | 500 @ 0.00 (0.00 %) | Amol Ashtekar |
| BSE 26-Aug-2024 26-Aug-2024 | Sell Market | 500 @ 0.00 (0.00 %) | Amol Ashtekar |
| BSE 05-Jul-2024 05-Jul-2024 | Buy ESOP | 950 @ 0.00 (0.00 %) | Rajeev Waybhat |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 300 @ 0.00 (0.00 %) | Rajeev Waybhat |
| BSE 26-Aug-2024 26-Aug-2024 | Sell Market | 1,250 @ 0.00 (0.00 %) | Rajeev Waybhat |
| BSE 31-Jul-2024 31-Jul-2024 | Sell Market | 675 @ 0.00 (0.00 %) | RANVIJAI SINGH BHADHURIA |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 45,000 @ 0.00 (0.00 %) | ANKIT MAHESHWARI |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 6,250 @ 0.00 (0.01 %) | DEEPAK MISHRA |
| BSE 02-Jul-2024 02-Jul-2024 | Buy ESOP | 675 @ 0.00 (0.00 %) | RANVIJAI SINGH BHADHURIA |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 16,300 @ 0.00 (0.00 %) | RANVIJAI SINGH BHADHURIA |
| BSE 08-Aug-2024 08-Aug-2024 | Buy ESOP | 68,750 @ 0.00 (0.00 %) | VISHAL SALVI |
| BSE 18-Jun-2024 18-Jun-2024 | Sell Block Deal | 5,817,570 @ 0.00 (10.86 %) | KAILASH SAHEBRAO KATKAR |
| BSE 18-Jun-2024 18-Jun-2024 | Buy Block Deal | 5,817,570 @ 0.00 (10.86 %) | ANUPAMA KAILASH KATKAR |
| BSE 29-May-2024 29-May-2024 | Buy ESOP | 15,275 @ 0.00 (0.03 %) | NETRA DESHPANDE |
| BSE 27-Mar-2024 27-Mar-2024 | Buy ESOP | 3,000 @ 0.00 (0.00 %) | DEEPAK MISHRA |
| BSE 07-Mar-2024 07-Mar-2024 | Sell Invocation Of Pledged | 2,060 @ 0.00 (0.00 %) | ASHISH KUMAR SINHA |
| BSE 15-Feb-2024 15-Feb-2024 | Sell Invocation Of Pledged | 1,750 @ 0.00 (0.00 %) | JANAKBAHADUR PUSHKARSINGH GURUNG |
| BSE 07-Mar-2024 07-Mar-2024 | Sell Invocation Of Pledged | 1,500 @ 0.00 (0.00 %) | JANAKBAHADUR PUSHKARSINGH GURUNG |
| BSE 04-Mar-2024 04-Mar-2024 | Sell Market | 2,000 @ 0.00 (0.00 %) | DEEPAK MISHRA |
| BSE 27-Feb-2024 27-Feb-2024 | Sell Market | 500 @ 0.00 (0.00 %) | OMKAR SHENOLIKAR |
BULK BLOCK DEALS FOR QUICK HEAL TECHNOLOGIES LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 18-Jun-2024 | Buy BULK | 5,817,570 @ 489.00 | ANUPAMA KAILASH KATKAR |
| BSE 18-Jun-2024 | Sell BULK | 5,817,570 @ 489.00 | KAILASH SAHEBRAO KATKAR |
| BSE 18-Jun-2024 | Sell BLOCK | 5,817,570 @ 489.00 | KAILASH SAHEBRAO KATKAR |
| BSE 18-Jun-2024 | Buy BLOCK | 5,817,570 @ 489.00 | ANUPAMA KAILASH KATKAR |
| BSE 28-Sep-2023 | Buy BULK | 750,000 @ 240.00 | CARNELIAN ASSET ADVISORS PRIVATE LIMITED |
| BSE 28-Sep-2023 | Sell BULK | 1,360,975 @ 240.00 | SEQUOIA CAPITAL INDIA INVESTMENT HOLDINGS III |
DIVIDEND BY QUICK HEAL TECHNOLOGIES LIMITED
| Ex Dividend Date | Dividend Type | Dividend |
|---|---|---|
| 30-Aug-2024 | DIVIDEND | 3 |
| 28-Jul-2023 | DIVIDEND | 2.5 |
| 18-Aug-2022 | DIVIDEND | 4.5 |
| 29-Jul-2021 | DIVIDEND | 4 |
SPLIT / BONUS BY QUICK HEAL TECHNOLOGIES LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
